Your Subtitle text
 


ITEM NUMBER:
80204
60 softgels  |  60 servings

Phosphatidylserine (PS) regulates brain cell function, and processing of information. Our Soy-free, Non-GMO formulation helps the body to rejuvenate brain cells while simultaneously improving memory and boosting brain function.*


In human clinical studies, PS supplementation has shown a clinical effect on the symptoms of AAMI, which includes reducing the risk of dementia and cognitive dysfunction. Moreover, it has been found that PS may help “turn back” the aging process*

May benefit younger populations, including young adults seeking to maintain a sharp mind and control stress as well as students seeking improvement of their learning abilities and performance*

Dosage of 300 mg/day for 6-8 weeks, followed by a maintenance period of 100 mg/day may improve symptoms of Alzheimer’s*

Can help to improve brain glucose metabolism*

Improves age-associated cognitive decline. Other capacities were exhibited as well including improvement of learning and remembering written information, recognition of persons, and memory of numbers*

Research shows Phosphatidylserine helped to improve recovery times and prevented muscle soreness in athletes involved with endurance running, weight training and cycling by helping to reduce Cortisol production*

PS exerts favorable effects on overall cell metabolism*

May help boost exercise capacity and improve athletic performance*

Soy-free formula*

Soy allergies are reportedly on the rise and more than 70 years of studies link soy foods to malnutrition, digestive distress, thyroid disorders, immune system breakdown, allergies, asthma, ADD/ADHD, reproductive problems (including infertility and loss of libido), heart disease and cancer*

Human studies provide evidence that PS is safe even at high levels – No significant effects were observed in safety parameters, blood pressure, heart rate, and adverse events subsequent to supplementation of 600 mg PS daily for 12 weeks. This evidence is further supported by the absence of reports of adverse reactions in the published literature*